Baird Downgrades Voyager Therapeutics (VYGR) to Neutral
Tweet
Share
E-mailGet Alerts VYGR Hot Sheet
Price: $3.27 +1.55%
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Baird analyst Brian Skorney downgraded Voyager Therapeutics (NASDAQ: VYGR) from Outperform to Neutral with a price target of $6.00.
For an analyst ratings summary and ratings history on Voyager Therapeutics click here. For more ratings news on Voyager Therapeutics click here.
Shares of Voyager Therapeutics closed at $6.23 yesterday.
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Citizens Downgrades Accelerant Holdings (ARX) to Market Perform
- Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
